Market Tracker

10/20 5:14pm ET

TherapeuticsMD Inc (NYSE MKT LLC:TXMD)

During the Trading Day
4.04 +0.07 / +1.76%
Data as of 4:03pm ET
Day’s Change
During After-Hours   Switch to standard view »
4.04 0.00 / 0.00%
 
Volume: 6.2K

Today’s Trading

Previous close3.97
Today’s open3.98
Day’s range3.93 - 4.18
Volume1,792,883
Average volume (3 months)1,453,870
Market cap$618.6M
Dividend yield--
Data as of 4:03pm ET, 10/20/2014

Growth & Valuation

Earnings growth (last year)+42.11%
Earnings growth (this year)-34.55%
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+129.85%
P/E ratioNM
Price/Sales75.74
Price/Book10.52

Competitors

 Today’s
change
Today’s
% change
INFIInfinity Pharmaceuti...+0.17+1.33%
TTPHTetraphase Pharmaceu...-0.56-2.32%
DRTXDurata Therapeutics ...+0.04+0.17%
TBPHTheravance Biopharma...+0.55+2.73%
Data as of 3:59pm ET, 10/20/2014

Financials

Next reporting dateNovember 3, 2014
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$8.8M
Annual profit (last year)-$28.4M
Net profit margin-323.84%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Robert G. Finizio
President, Secretary &
Director
John C. K. Milligan
Corporate headquarters
Boca Raton, Florida

Forecasts